Table 1

Simple association of analysed variables with RET

Variable and typep Value
Continuous variablesMean (no RET)Mean (RET)
 Systolic blood pressure, mm Hg126.58117.10<0.001
 Haemoglobin, g/L101.2492.52<0.001
 Urea, mmol/L14.6417.86<0.001
 Diastolic blood pressure, mm Hg68.4864.20<0.001
 Pulse, beats/min88.2791.540.01
 Platelets, ×1012 cells/L279.41258.710.02
 Age, years68.2068.730.60
 Creatinine, μmol/L126.57123.620.66
 INR1.571.590.84
Categorical variablesORχ2 statistic
 Fresh melaena3.0871.29<0.001
 Old melaena0.2938.16<0.001
 Coffee ground vomitus0.2927.13<0.001
 Fresh haematemesis1.6714.12<0.001
 Per rectum bleeding0.922.920.23
 Sex (male)1.498.39<0.001
 Ethnicity: NZ European (reference level)1.00NANA
 Ethnicity: Maori1.241.620.20
 Year of bleeding event1.426.900.01
 History of peptic ulcer disease1.834.620.03
 Inpatient status1.134.250.12
 Duration of symptoms less than 8 h before presentation1.313.240.07
 Syncope on presentation1.372.930.09
 Ranitidine use2.054.570.03
 PPI use0.782.480.12
 Warfarin use1.282.370.12
 NSAID or aspirin use0.762.000.16
 NSAID use1.191.670.20
 Clexane use1.250.400.53
 Thrombolysis in past 28 days0.960.270.60
 Unfractionated heparin use1.490.220.64
 Clopidogrel use0.661.210.27
 Aspirin use0.480.980.32
 Dipyridamole use0.920.000.96
 Presence of disseminated cancer0.393.500.06
 Ischaemic heart disease1.140.860.35
 Gastric or oesophageal cancer1.150.830.36
 Chronic renal impairment0.000.780.38
 Diabetes1.090.210.65
 COPD1.100.110.74
 Rheumatoid arthritis1.290.050.83
 Previous stroke0.940.030.86
 Congestive cardiac failure1.040.020.90
 ASA score1.080.670.96
  • Variable ‘year of bleeding event’ defined as a dichotomous variable: ie, either the first or the second half of the study period.

  • ASA, American Society of Anaesthesiology; COPD, chronic obstructive pulmonary disease; INR, international normalised ratio; NSAID, non-steroidal anti-inflammatory drug; PPI, proton pump inhibitor; RET, requirement of endoscopic therapy.